In a significant crackdown on the illicit trade of counterfeit pharmaceuticals, a joint operation was conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal. A press release on the raid was issued on December 31, 2024.
The raid targeted a wholesale premises located in Kolkata, and led to the seizure of a substantial quantity of suspected spurious drugs, including anti-cancer and anti-diabetic medications.
The seized drugs, labeled as originating from countries such as Ireland, Turkey, the USA, and Bangladesh, lacked any accompanying documentation to verify their legitimate importation into India. In the absence of such evidence, the drugs are classified as spurious under Indian law. Additionally, investigators discovered empty packing materials at the site, further raising concerns about the authenticity of the products.
The estimated market value of the confiscated drugs is Rs. 6.60 crore. Samples of the seized medicines have been sent for quality testing, while the remaining stock is under the safe custody of the CDSCO.
Arrest and Judicial Custody
The proprietor of the wholesale firm, a woman, was arrested during the raid by the Drugs Inspector of CDSCO, East Zone. Following her arrest, she was presented before the court, which has placed her under judicial custody for 14 days, permitting further interrogation as part of the ongoing investigation.
Government’s Zero-Tolerance Approach
This operation highlights the Indian government’s unwavering commitment to ensuring public health and safety. The Ministry of Health and Family Welfare has reiterated its zero-tolerance policy towards counterfeit and substandard drugs in the market.
In a statement, officials emphasized that the CDSCO and state authorities will continue to collaborate to tackle the menace of spurious drugs and protect consumers. The successful raid underscores the importance of vigilance in combating threats to the pharmaceutical supply chain.
Further investigations are underway to trace the origins of the counterfeit drugs and identify other individuals or entities involved in the illegal trade.
